Comparative analysis of cell compositions between healthy and SLE PBMC datasets (Fig. 5b) highlighted significant shifts in CD4+ T cells and CD14+ monocyte levels, reflecting known SLE immunopathology and validating PredGCN’s accuracy. This evidence concerns the gene CD14 and systemic lupus erythematosus.